Does the p70S6K Specific Inhibitor PF-4708671 impede Non-Small Cell Lung Cancer Growth?
These findings demonstrated that the p70S6K specific inhibitor PF-4708671 has inhibitory effects on NSCLC tumorigenesis in vitro and in vivo. Therefore, P70S6K should be considered a new potential therapeutic target, and PF-470867 may be used as targeted drug for cancer treatment.
3D imaging seems not to influence the performance time of LC by an experienced laparoscopic surgeon. Less experienced laparoscopic surgeons could benefit from shorter performance time with 3D imaging due to no need to adapt to 2D vision. Further comparative studies are necessary to verify on great numbers of cases whether 3D can reduce intraoperative complications such as biliary lesions.